Remove Patients Remove Prescription Remove Retail
article thumbnail

Breaking Down Patient Access Barriers

PM360

After nearly five years of mounting pressures on the American healthcare system, providers and patients are confronting another challenge that shows no signs of slowing down: skyrocketing medical costs. Patients with low incomes are especially vulnerable.

article thumbnail

The future of healthcare?

World of DTC Marketing

Patients have wanted this for a long time. In my opinion, these total urgent care centers will be springing up throughout the US and could even be branded under retailers like Wal*Mart or Target. One urgent care center has an area just for prescription drug brochures, and I was surprised to see so many people reading them.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DTC forecasts are not really that reliable

World of DTC Marketing

of all US digital ad spending, which is much smaller than top spenders like retail (21.0%) and financial services (14.6%), but larger than entertainment (5.2%), media (4.7%), and travel (2.4%)” Pharma’s first love will always be TV, and that’s where the most significant slice of the budget goes.

Pharma 227
article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Speciality care.

Retail 45
article thumbnail

Health consumers: A long way off

World of DTC Marketing

Today, just as many people trust retailers and digital companies to help manage their personal health as they do health care providers.18. The emerging health consumer isn’t so much seeking to consume health care. S/he’s in search of health, wellness, and betterment. But there are problems. Forty-three of fifty U.S.

article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

article thumbnail

Eli Lilly Announces Availability of Obesity Drug Zepbound at US Pharmacies

PharmExec

Patients with obesity are now able to access Zepbound (tirzepatide) with a prescription at retail and mail-order pharmacies across six dose strengths.

Retail 64